Novartis (NYSE: NVS) reported Q3 EPS of $1.26, $0.05 worse than the analyst estimate of $1.31. Revenue for the quarter ...

This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE